ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

Clinical trial NCT06090864 · RECRUITING

Trial details

NCT number: NCT06090864
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hodgkin Lymphoma Relapse Refractory

Start date: 2024-04-25
Primary completion: 2028-08-03
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.